Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totalling 400 shares, a drop of 75.0% from the November 30th total of 1,600 shares. Based on an average trading volume of 280,200 shares, the short-interest ratio is presently 0.0 days.
Analyst Ratings Changes
Separately, The Goldman Sachs Group initiated coverage on shares of Merck KGaA in a report on Thursday, September 19th. They issued a “buy” rating on the stock.
Read Our Latest Stock Analysis on Merck KGaA
Merck KGaA Stock Down 0.1 %
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Further Reading
- Five stocks we like better than Merck KGaA
- How to Calculate Return on Investment (ROI)
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What is the Nasdaq? Complete Overview with History
- Top 3 ETFs to Hedge Against Inflation in 2025
- Airline Stocks – Top Airline Stocks to Buy Now
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.